Form 8-K - Current report:
SEC Accession No. 0001193125-25-004045
Filing Date
2025-01-10
Accepted
2025-01-10 06:30:18
Documents
15
Period of Report
2025-01-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d925938d8k.htm   iXBRL 8-K 32123
2 EX-99.1 d925938dex991.htm EX-99.1 23398
6 GRAPHIC g925938g98k99.jpg GRAPHIC 5874
  Complete submission text file 0001193125-25-004045.txt   199186

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rapp-20250109.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rapp-20250109_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rapp-20250109_pre.xml EX-101.PRE 11712
17 EXTRACTED XBRL INSTANCE DOCUMENT d925938d8k_htm.xml XML 3768
Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42121 | Film No.: 25520254
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)